12/4
04:48 pm
phr
Phreesia's Megan Turco Named to MM+M 40 Under 40 [Yahoo! Finance]
Low
Report
Phreesia's Megan Turco Named to MM+M 40 Under 40 [Yahoo! Finance]
12/4
04:05 pm
phr
Phreesia’s Megan Turco Named to MM+M 40 Under 40
Low
Report
Phreesia’s Megan Turco Named to MM+M 40 Under 40
12/2
09:40 am
phr
Phreesia (NYSE:PHR) had its price target raised by analysts at DA Davidson from $33.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
Phreesia (NYSE:PHR) had its price target raised by analysts at DA Davidson from $33.00 to $35.00. They now have a "buy" rating on the stock.
12/1
11:38 am
phr
Phreesia (PHR) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]
Low
Report
Phreesia (PHR) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]
11/19
04:34 pm
phr
Phreesia Named to the 2025 Deloitte Technology Fast 500™ [Yahoo! Finance]
Medium
Report
Phreesia Named to the 2025 Deloitte Technology Fast 500™ [Yahoo! Finance]
11/19
04:05 pm
phr
Phreesia Named to the 2025 Deloitte Technology Fast 500™
Low
Report
Phreesia Named to the 2025 Deloitte Technology Fast 500™
11/13
08:11 am
phr
Phreesia (NYSE:PHR) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $32.00 price target on the stock.
Low
Report
Phreesia (NYSE:PHR) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $32.00 price target on the stock.
11/12
08:48 am
phr
Clinical Trials Matching Software Market Size to Reach USD 501.86 Million by 2032, Driven by AI and EHR Integration – SNS Insider [Yahoo! Finance]
Low
Report
Clinical Trials Matching Software Market Size to Reach USD 501.86 Million by 2032, Driven by AI and EHR Integration – SNS Insider [Yahoo! Finance]
11/3
04:04 pm
phr
Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results
Low
Report
Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results
10/31
01:04 pm
phr
Phreesia (NYSE:PHR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Phreesia (NYSE:PHR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/21
07:03 pm
phr
Phreesia (PHR) Fell in Q3 Despite Reporting Better Results [Yahoo! Finance]
Low
Report
Phreesia (PHR) Fell in Q3 Despite Reporting Better Results [Yahoo! Finance]
10/14
10:25 am
phr
Qualifacts Named One of the Top 25 Healthcare Software Companies of 2025 by The Healthcare Technology Report [Yahoo! Finance]
Neutral
Report
Qualifacts Named One of the Top 25 Healthcare Software Companies of 2025 by The Healthcare Technology Report [Yahoo! Finance]
10/8
04:43 pm
phr
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling [Yahoo! Finance]
Low
Report
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling [Yahoo! Finance]
10/8
04:05 pm
phr
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling
Low
Report
Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling
10/8
08:05 am
phr
Phreesia (NYSE:PHR) was given a new $32.00 price target on by analysts at KeyCorp.
Low
Report
Phreesia (NYSE:PHR) was given a new $32.00 price target on by analysts at KeyCorp.
9/30
05:16 pm
phr
Phreesia Named to TIME's 2025 List of the World's Top HealthTech Companies [Yahoo! Finance]
Medium
Report
Phreesia Named to TIME's 2025 List of the World's Top HealthTech Companies [Yahoo! Finance]
9/30
04:05 pm
phr
Phreesia Named to TIME’s 2025 List of the World’s Top HealthTech Companies
Medium
Report
Phreesia Named to TIME’s 2025 List of the World’s Top HealthTech Companies
9/16
06:49 am
phr
Becker’s Names Phreesia’s Sara DiNardo as one of 2025’s Rising Stars of Healthcare
Low
Report
Becker’s Names Phreesia’s Sara DiNardo as one of 2025’s Rising Stars of Healthcare
9/10
03:34 pm
phr
Phreesia (PHR) Reports Q2 Earnings with Sales Rising from US$28M to US$35M [Yahoo! Finance]
Neutral
Report
Phreesia (PHR) Reports Q2 Earnings with Sales Rising from US$28M to US$35M [Yahoo! Finance]
9/9
03:17 pm
phr
Phreesia (NYSE:PHR) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Phreesia (NYSE:PHR) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
9/9
05:56 am
phr
Phreesia (NYSE:PHR) was upgraded by analysts at DA Davidson to a "strong-buy" rating.
Low
Report
Phreesia (NYSE:PHR) was upgraded by analysts at DA Davidson to a "strong-buy" rating.
9/8
10:28 am
phr
Phreesia (NYSE:PHR) had its price target raised by analysts at JMP Securities from $30.00 to $34.00. They now have a "market outperform" rating on the stock.
Medium
Report
Phreesia (NYSE:PHR) had its price target raised by analysts at JMP Securities from $30.00 to $34.00. They now have a "market outperform" rating on the stock.
9/8
08:03 am
phr
Phreesia (NYSE:PHR) was given a new $33.00 price target on by analysts at Raymond James Financial, Inc..
Medium
Report
Phreesia (NYSE:PHR) was given a new $33.00 price target on by analysts at Raymond James Financial, Inc..
9/8
08:03 am
phr
Phreesia (NYSE:PHR) was given a new $36.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Phreesia (NYSE:PHR) was given a new $36.00 price target on by analysts at Truist Financial Corporation.